Evidence map›Paper›PMID 25680754›Full record

ArticleMolecular pharmacology2015

Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular traffic.

Catalin M Filipeanu, Ashok K Pullikuth, Jessie J Guidry

Abstract read
In one paragraph

Article in Molecular pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Catalin M FilipeanuDepartment of Pharmacology, College of Medicine, Howard University, Washington, DC (C.M.F.); Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana (A.K.P., J.J.G.); Department of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, North Carolina (A.K.P.); and Louisiana State University Health Sciences Center Proteomics Core Facility, New Orleans, Louisiana (J.J.G.) catalin.filipeanu@howard.edu.
Ashok K PullikuthDepartment of Pharmacology, College of Medicine, Howard University, Washington, DC (C.M.F.); Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana (A.K.P., J.J.G.); Department of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, North Carolina (A.K.P.); and Louisiana State University Health Sciences Center Proteomics Core Facility, New Orleans, Louisiana (J.J.G.).
Jessie J GuidryDepartment of Pharmacology, College of Medicine, Howard University, Washington, DC (C.M.F.); Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana (A.K.P., J.J.G.); Department of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, North Carolina (A.K.P.); and Louisiana State University Health Sciences Center Proteomics Core Facility, New Orleans, Louisiana (J.J.G.).

Funding

Vascular and Cardiac Function Core - "Mentoring in Cardiovascular BiologyP30GM106392 · NIGMS · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2014 to 2018
$5.5M
MENTORING IN CARDIOVASCULAR BIOLOGYP20GM103514 · NIGMS · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2012 to 2012
$2.0M
Targeting accessory proteins of alpha2C adrenergic receptor in Raynaud PhenomenonR03AR064008 · NIAMS · LSU HEALTH SCIENCES CENTER · PI FILIPEANU, CATALIN · 2013 to 2015
$225k
NIAMS NIH HHS R03 AR064008NIAMS NIH HHS R03-AR064008NIGMS NIH HHS P20 GM103514NIGMS NIH HHS P20-GM103514NIGMS NIH HHS P30 GM106392
6 · The paper itself

Abstract

The human α2C-adrenergic receptor (α2C-AR) is localized intracellularly at physiologic temperature. Decreasing the environmental temperature strongly stimulates the receptor transport to the cell surface. In contrast, rat and mouse α2C-AR plasma membrane levels are less sensitive to decrease in temperature, whereas the opossum α2C-AR cell surface levels are not changed in these conditions. Structural analysis demonstrated that human α2C-AR has a high number of arginine residues in the third intracellular loop and in the C-terminus, organized as putative RXR motifs. Although these motifs do not affect the receptor subcellular localization at 37°C, deletion of the arginine clusters significantly enhanced receptor plasma membrane levels at reduced temperature. We found that this exaggerated transport of the human receptor is mediated by two functional arginine clusters, one in the third intracellular loop and one in the C-terminus. This effect is mediated by interactions with COPI vesicles, but not by 14-3-3 proteins. In rat α2C-AR, the arginine cluster from the third intracellular loop is shifted to the left due to three missing residues. Reinsertion of these residues in the rat α2C-AR restored the same temperature sensitivity as in the human receptor. Proteomic and coimmunoprecipitation experiments identified pontin as a molecule having stronger interactions with human α2C-AR compared with rat α2C-AR. Inhibition of pontin activity enhanced human receptor plasma membrane levels and signaling at 37°C. Our results demonstrate that human α2C-AR has a unique temperature-sensitive traffic pattern within the G protein-coupled receptor class due to interactions with different molecular chaperones, mediated in part by strict spatial localization of specific arginine residues.

Indexed as

AnimalsArginineCell LineCell MembraneCytoplasmHEK293 CellsHumansProtein TransportProteomicsRatsReceptors, Adrenergic, alpha-2Receptors, G-Protein-CoupledSignal TransductionTemperatureArginineReceptors, Adrenergic, alpha-2Receptors, G-Protein-Coupled

Identifiers

PMID25680754
PMCPMC4407737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.